4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine

C122H158N28O13S7 — CID 158247074

IUPAC4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine
SMILESCC(C)CCOC(c1nccs1)C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1.CN(C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)S(=O)(=O)c1nccs1.O=S(=O)(CC1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)c1nccs1.c1csc(C(OCCN2CCCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1.c1csc(C(OCCN2CCOCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1
InChIInChI=1S/C27H36N6O3S.C27H36N6O2S.C26H35N5O2S.C21H26N6O3S2.C21H25N5O3S2/c1-2-21(25(27-28-5-17-37-27)36-16-9-31-7-12-34-13-8-31)19-33(6-1)26-23-4-3-22(18-24(23)29-20-30-26)32-10-14-35-15-11-32;1-2-9-31(8-1)11-16-35-25(27-28-7-17-36-27)21-4-3-10-33(19-21)26-23-6-5-22(18-24(23)29-20-30-26)32-12-14-34-15-13-32;1-19(2)7-12-33-24(26-27-8-15-34-26)20-4-3-9-31(17-20)25-22-6-5-21(16-23(22)28-18-29-25)30-10-13-32-14-11-30;1-25(32(28,29)21-22-6-12-31-21)17-3-2-7-27(14-17)20-18-5-4-16(13-19(18)23-15-24-20)26-8-10-30-11-9-26;27-31(28,21-22-5-11-30-21)14-16-2-1-6-26(13-16)20-18-4-3-17(12-19(18)23-15-24-20)25-7-9-29-10-8-25/h3-5,17-18,20-21,25H,1-2,6-16,19H2;5-7,17-18,20-21,25H,1-4,8-16,19H2;5-6,8,15-16,18-20,24H,3-4,7,9-14,17H2,1-2H3;4-6,12-13,15,17H,2-3,7-11,14H2,1H3;3-5,11-12,15-16H,1-2,6-10,13-14H2
InChIKeyGGGCJHRZRBXMFK-UHFFFAOYSA-N
MW2449.26 g/mol
LogP16.99
Rot. Bonds34

About 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine

4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine (PubChem CID 158247074) has the molecular formula C122H158N28O13S7 and a molecular weight of 2449.26 g/mol. Its IUPAC name is 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine.

Molecular Properties

Compound Name4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine
PubChem CID158247074
Molecular FormulaC122H158N28O13S7
Molecular Weight2449.26 g/mol
Exact Mass2447.06
IUPAC Name4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine
SMILESCC(C)CCOC(c1nccs1)C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1.CN(C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)S(=O)(=O)c1nccs1.O=S(=O)(CC1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)c1nccs1.c1csc(C(OCCN2CCCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1.c1csc(C(OCCN2CCOCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1
InChIInChI=1S/C27H36N6O3S.C27H36N6O2S.C26H35N5O2S.C21H26N6O3S2.C21H25N5O3S2/c1-2-21(25(27-28-5-17-37-27)36-16-9-31-7-12-34-13-8-31)19-33(6-1)26-23-4-3-22(18-24(23)29-20-30-26)32-10-14-35-15-11-32;1-2-9-31(8-1)11-16-35-25(27-28-7-17-36-27)21-4-3-10-33(19-21)26-23-6-5-22(18-24(23)29-20-30-26)32-12-14-34-15-13-32;1-19(2)7-12-33-24(26-27-8-15-34-26)20-4-3-9-31(17-20)25-22-6-5-21(16-23(22)28-18-29-25)30-10-13-32-14-11-30;1-25(32(28,29)21-22-6-12-31-21)17-3-2-7-27(14-17)20-18-5-4-16(13-19(18)23-15-24-20)26-8-10-30-11-9-26;27-31(28,21-22-5-11-30-21)14-16-2-1-6-26(13-16)20-18-4-3-17(12-19(18)23-15-24-20)25-7-9-29-10-8-25/h3-5,17-18,20-21,25H,1-2,6-16,19H2;5-7,17-18,20-21,25H,1-4,8-16,19H2;5-6,8,15-16,18-20,24H,3-4,7,9-14,17H2,1-2H3;4-6,12-13,15,17H,2-3,7-11,14H2,1H3;3-5,11-12,15-16H,1-2,6-10,13-14H2
InChIKeyGGGCJHRZRBXMFK-UHFFFAOYSA-N
XLogP16.99
TPSA386.82 Ų
H-Bond Donors
H-Bond Acceptors45
Rotatable Bonds34
Heavy Atoms170
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002449.26
LogP ≤ 516.99
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1045

Analyze 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine?
The IUPAC name of 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine (CID 158247074) is 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine.
What is the SMILES notation for 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine?
The canonical SMILES for 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine is CC(C)CCOC(c1nccs1)C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1.CN(C1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)S(=O)(=O)c1nccs1.O=S(=O)(CC1CCCN(c2ncnc3cc(N4CCOCC4)ccc23)C1)c1nccs1.c1csc(C(OCCN2CCCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1.c1csc(C(OCCN2CCOCC2)C2CCCN(c3ncnc4cc(N5CCOCC5)ccc34)C2)n1.
What is the InChIKey of 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine?
The InChIKey is GGGCJHRZRBXMFK-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H36N6O3S.C27H36N6O2S.C26H35N5O2S.C21H26N6O3S2.C21H25N5O3S2/c1-2-21(25(27-28-5-17-37-27)36-16-9-31-7-12-34-13-8-31)19-33(6-1)26-23-4-3-22(18-24(23)29-20-30-26)32-10-14-35-15-11-32;1-2-9-31(8-1)11-16-35-25(27-28-7-17-36-27)21-4-3-10-33(19-21)26-23-6-5-22(18-24(23)29-20-30-26)32-12-14-34-15-13-32;1-19(2)7-12-33-24(26-27-8-15-34-26)20-4-3-9-31(17-20)25-22-6-5-21(16-23(22)28-18-29-25)30-10-13-32-14-11-30;1-25(32(28,29)21-22-6-12-31-21)17-3-2-7-27(14-17)20-18-5-4-16(13-19(18)23-15-24-20)26-8-10-30-11-9-26;27-31(28,21-22-5-11-30-21)14-16-2-1-6-26(13-16)20-18-4-3-17(12-19(18)23-15-24-20)25-7-9-29-10-8-25/h3-5,17-18,20-21,25H,1-2,6-16,19H2;5-7,17-18,20-21,25H,1-4,8-16,19H2;5-6,8,15-16,18-20,24H,3-4,7,9-14,17H2,1-2H3;4-6,12-13,15,17H,2-3,7-11,14H2,1H3;3-5,11-12,15-16H,1-2,6-10,13-14H2.
What are the key properties of 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine?
4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine has a molecular weight of 2449.26 g/mol, XLogP of 16.99, 34 rotatable bonds, 0 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[3-[3-methylbutoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;N-methyl-N-[1-(7-morpholin-4-ylquinazolin-4-yl)piperidin-3-yl]-1,3-thiazole-2-sulfonamide;4-[4-[3-[2-morpholin-4-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-[2-pyrrolidin-1-ylethoxy(1,3-thiazol-2-yl)methyl]piperidin-1-yl]quinazolin-7-yl]morpholine;4-[4-[3-(1,3-thiazol-2-ylsulfonylmethyl)piperidin-1-yl]quinazolin-7-yl]morpholine is sourced from PubChem (CID 158247074), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).